30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Reimbursement / Regulatory

Episurf Medical Receives CE Mark Approval for EpiGuide® MOS -

Episurf Medical received approval under the CE Mark for the EpiGuide® MOS, its fourth patient-specific application for the treatment of knee cartilage lesions. EpiGuide MOS is a precision tool kit for the mosaicplasty procedure, a biological knee treatment aimed at people aged 20 to 40 years which are considered too young for the Episealer® implant. The product is slated for early 1Q16 launch.

EpiGuide MOS can fit any mosaicplasty tools, offering surgeons an accessible guide kit that helps them improve accuracy and precision during the repair procedure.

Source: Episurf Medical

The company is experiencing a year of healthy growth, posting 3Q15 revenue of SEK 150,174 (~US $17,380), +91.9% vs. 3Q14, and YTD 2015 sales of SEK 641,094 (~$74,200), +441% vs. the prior year.

This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.